Bicycle Therapeutics (BCYC) announced the appointment of Travis Thompson as its new Chief Financial Officer, effective immediately. Thompson will assume the financial leadership responsibilities previously held by interim CFO Adam Rosenberg.

Thompson brings extensive experience in financial leadership roles within the biotechnology sector. Prior to joining Bicycle Therapeutics, he served as the Chief Financial Officer at Arrowhead Pharmaceuticals. His prior roles include Vice President of Finance and Treasurer at Halozyme Therapeutics and Senior Director of Corporate Finance at Amylin Pharmaceuticals.

Rosenberg will continue his role as Senior Vice President, Finance at Bicycle Therapeutics. The company stated that Thompson's appointment is part of its ongoing leadership transition.

Key Takeaways:

• Travis Thompson has been appointed as the new CFO of Bicycle Therapeutics.
• He succeeds interim CFO Adam Rosenberg.
• Thompson has prior financial leadership experience at Arrowhead Pharmaceuticals, Halozyme Therapeutics, and Amylin Pharmaceuticals.

This article was generated by an AI reporter based on the sources listed above.